Here’s a very helpful article from yesterday’s STAT News about what 23andMe’s genetic reports can and cannot show…. Full Story>
New York Times: F.D.A. Will Allow 23andMe to Sell Genetic Tests for Disease Risk to Consumers
On April 6, the New York Times reports that the FDA will allow 23andMe to sell genetic tests for disease risk to consumers. According to the article, customers have to specifically ask to be tested for Alzheimer’s and Parkinson’s risk.
EurekAlert! “Journal of Parkinson’s Disease celebrates key breakthroughs”
From the shaking palsy to alpha-synuclein, the stories behind the science from many of the researchers who played key roles in achieving significant milestones are published.
New York Times: Hepatitis Tied to Parkinson’s Risk
Hepatitis infection may increase the risk for Parkinson’s disease, though the reasons for the link remain unknown.
British investigators used records of 100,390 patients hospitalized with various forms of hepatitis or H.I.V. from 1999 to 2011. They compared Parkinson’s incidence in these patients with incidence in more than six million people admitted for medical or surgical conditions like cataracts, knee replacement or varicose veins.
Seeing a movement disorders specialist at Stanford and elsewhere, plus other great PD resources
The Stanford American Parkinson Disease Association Information & Referral (I&R) Center often receives calls or email inquiries about finding a movement disorder specialist, physical therapist, speech therapist, or other resources in Northern and Central California. Many people call us about making an appointment at Stanford. Read more about how to make an appointment at Stanford and how the I&R Center can help you.
… Full Story>- « Previous Page
- 1
- …
- 39
- 40
- 41
- 42
- 43
- …
- 47
- Next Page »